CheckMyRecalls

Cipla Limited recalls Phytonadione Injectable Emulsion

Published
10 Dec 2025
Units affected
4,438 10x1mL cartons
Agency
FDA
Country
United States

The hazard

Failed Stability Specifications: Observed OOS results: eg results for colour index

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Phytonadione Injectable Emulsion, USP 10mg/mL, 10x1 mL Single-Dose Vial/carton, Rx Only, Mfd. by: Cipla Ltd. India At M/s Immacule Lifesciences PVT. Ltd. India. Mfd. for: Cipla USA, Inc. Warren, NJ 07059. Vial NDC# 69097-708-31; Carton NDC 69097-708-96

Brand / company
Cipla Limited
Codes / lots
Batch # PH0072404A, PH0082404A, Exp. Date December 31, 2025
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 10 Dec 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.